Back

Predictor of wasted implantable cardioverter defibrillator for secondary prevention

2 September 2024 (08:00 - 08:50)
Organised by: Logo
Congress Presentation Part of: Ventricular arrhythmias: novel insights Device Treatment ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Ms Rie Akagawa

Niigata University Graduate School of Medical and Dental Sciences, Niigata (Japan)

8 More presentations in this session

Presentation thumbnail
Prospective assessment of risk factors for appropriate ICD intervention in patients with ischemic cardiomyopathy: results of PARCADIA trial
Mr L. Voorhout (Arnhem, NL)
Abstract Slides Video
Presentation thumbnail
The relative importance of ischaemia and scar in the genesis of ventricular arrhythmia in ischaemic cardiomyopathy
Doctor H. Morgan (London, GB)
Abstract Slides Video
Presentation thumbnail
Mineralocorticoid receptor antagonist therapy in patients with ischemic heart failure and ventricular tachycardia: a comparative analysis of spironolactone vs. eplerenone
Doctor I. Szakal (Budapest, HU)
Abstract Slides Video
Presentation thumbnail
Right ventricular outflow tract arrhythmias in patients with obstructive sleep apnea- electrophysiological insights
Doctor A. Negru (Timisoara, RO)
Abstract Slides Video
Presentation thumbnail
Low levels of apolipoprotein M are associated with increased risk of ventricular arrhythmias
Associate Professor P. Myhre (Oslo, NO)
Abstract Slides Video

Access the full session

Session thumbnail
Ventricular arrhythmias: novel insights

The Event

Event poster

ESC Congress 2024

2 September 2024 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Predictors of implantable cardioverter-defibrillator therapies: a 6-year follow-up study
thumbnail
Congress Presentation
Risk for appropriate ICD intervention and complications in patients implanted after an out-hospital cardiac arrest compared to patients implanted for primary and other secondary prevention indication
thumbnail
Congress Presentation
Assessing the benefit of a replacement implantable cardioverter-defibrillator device for primary prevention of sudden cardiac death

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources